Uracil-directed ligand tethering: an efficient strategy for uracil DNA glycosylase (UNG) inhibitor development.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of the American Chemical Society

• Publication date

  2005-11-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JA055846NPMID 16332091PMCID PMC2522323
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Binding energy, specificity, and enzymic catalysis: the circe effect.

  2006cited by this paper
• Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment.

  2005cited by this paper
• HIV-1-associated uracil DNA glycosylase activity controls dUTP misincorporation in viral DNA and is essential to the HIV-1 life cycle.

  2005cited by this paper
• The origins of high-affinity enzyme binding to an extrahelical DNA base.

  2005cited by this paper
• Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase

  2005cited by this paper
• Structure of a repair enzyme interrogating undamaged DNA elucidates recognition of damaged DNA

  2005cited by this paper
• Ribonuclease activity of vaccinia DNA topoisomerase IB: kinetic and high-throughput inhibition studies using a robust continuous fluorescence assay.

  2004cited by this paper
• Dynamic opening of DNA during the enzymatic search for a damaged base

  2004cited by this paper
• A molecular beacon assay for measuring base excision repair activities.

  2004cited by this paper
• The merits of bipartite transition-state mimics for inhibition of uracil DNA glycosylase.

  2004cited by this paper
• Recognition of an unnatural difluorophenyl nucleotide by uracil DNA glycosylase.

  2004cited by this paper
• Vpr-mediated Incorporation of UNG2 into HIV-1 Particles Is Required to Modulate the Virus Mutation Rate and for Replication in Macrophages*

  2004cited by this paper
• Rational engineering of a DNA glycosylase specific for an unnatural cytosine:pyrene base pair.

  2003cited by this paper
• Incorporation of Uracil into Minus Strand DNA Affects the Specificity of Plus Strand Synthesis Initiation during Lentiviral Reverse Transcription*

  2003cited by this paper
• Human uracil–DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination

  2003cited by this paper
• Influence of Reverse Transcriptase Variants, Drugs, and Vpr on Human Immunodeficiency Virus Type 1 Mutant Frequencies

  2003cited by this paper
• A fission yeast homologue of the human uracil-DNA-glycosylase and their roles in causing DNA damage after overexpression.

  2003cited by this paper
• Vaccinia Virus Uracil DNA Glycosylase Has an Essential Role in DNA Synthesis That Is Independent of Its Glycosylase Activity: Catalytic Site Mutations Reduce Virulence but Not Virus Replication in Cultured Cells

  2003cited by this paper
• Electrostatic guidance of glycosyl cation migration along the reaction coordinate of uracil DNA glycosylase.

  2003cited by this paper
• Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase

  2002cited by this paper
• dUTPase and uracil-DNA glycosylase are central modulators of antifolate toxicity in Saccharomyces cerevisiae.

  2002cited by this paper
• An inhibitor of the human UDP-GlcNAc 4-epimerase identified from a uridine-based library: a strategy to inhibit O-linked glycosylation.

  2002cited by this paper
• Immunoglobulin genes: generating diversity with AID and UNG.

  2002cited by this paper
• Base-flipping mutations of uracil DNA glycosylase: substrate rescue using a pyrene nucleotide wedge.

  2002cited by this paper
• Roles of uracil-DNA glycosylase and dUTPase in virus replication.

  2002cited by this paper
• Mutational analysis of the base-flipping mechanism of uracil DNA glycosylase.

  2002cited by this paper
• Trypanosomal dUTPases as potential targets for drug design.

  2001cited by this paper
• The herpesvirus encoded dUTPase as a potential chemotherapeutic target.

  2001cited by this paper
• The role of dUTPase and uracil-DNA repair in cancer chemotherapy.

  2001cited by this paper
• The role of retroviral dUTPases in replication and virulence.

  2001cited by this paper
• Uracil DNA glycosylase: insights from a master catalyst.

  2001cited by this paper
• dUTPase in human neoplastic cells as a potential target for therapeutic intervention.

  2001cited by this paper
• Turning On Uracil-DNA Glycosylase Using a Pyrene Nucleotide Switch*

  2001cited by this paper
• Combinatorial target-guided ligand assembly: identification of potent subtype-selective c-Src inhibitors.

  2000cited by this paper
• Uracil-DNA glycosylase (UNG)-deficient mice reveal a primary role of the enzyme during DNA replication.

  2000cited by this paper
• Selective Inhibition of Herpes Simplex Virus Type-1 Uracil-DNA Glycosylase by Designed Substrate Analogs* 210

  2000cited by this paper
• The Interaction of Vpr with Uracil DNA Glycosylase Modulates the Human Immunodeficiency Virus Type 1 In Vivo Mutation Rate

  2000cited by this paper
• Suppression of Intestinal Polyposis inApc Δ 716 Knockout Mice by an Additional Mutation in the Cytosolic Phospholipase A2Gene*

  2000cited by this paper
• Escherichia coli uracil DNA glycosylase: NMR characterization of the short hydrogen bond from His187 to uracil O2.

  2000cited by this paper
• Human Immunodeficiency Virus and AIDS: Insights from Animal Lentiviruses

  2000cited by this paper
• Quality control by DNA repair.

  1999cited by this paper
• DNA Repair Enzyme Uracil DNA Glycosylase Is Specifically Incorporated into Human Immunodeficiency Virus Type 1 Viral Particles through a Vpr-Independent Mechanism

  1999cited by this paper
• Protein mimicry of DNA from crystal structures of the uracil-DNA glycosylase inhibitor protein and its complex with Escherichia coli uracil-DNA glycosylase.

  1999cited by this paper
• Diversity of HIV-1 Vpr Interactions Involves Usage of the WXXF Motif of Host Cell Proteins*

  1998cited by this paper
• Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest

  1997cited by this paper
• Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme

  1996cited by this paper
• Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase.

  1996cited by this paper
• Human cytomegalovirus uracil DNA glycosylase is required for the normal temporal regulation of both DNA synthesis and viral replication

  1996cited by this paper
• The structural basis of specific base-excision repair by uracil–DNA glycosylase

  1996cited by this paper
• Excision of cytosine and thymine from DNA by mutants of human uracil‐DNA glycosylase.

  1996cited by this paper
• Crystal structure and mutational analysis of human uracil-DNA glycosylase: structural basis for specificity and catalysis.

  1995cited by this paper
• A poxvirus-encoded uracil DNA glycosylase is essential for virus viability

  1993cited by this paper
• Herpes simplex virus-induced dUTPase: target site for antiviral chemotherapy.

  1988cited by this paper
• Synthesis and biological properties of 2-, 5-, and 6-fluoronorepinephrines.

  1979cited by this paper
• Synthesis and antihypertensive activity of 2-benzamido-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizines.

  1979cited by this paper
• Entropic contributions to rate accelerations in enzymic and intramolecular reactions and the chelate effect.

  1971cited by this paper

• Small-molecule activator of SMUG1 enhances repair of pyrimidine lesions in DNA.

  2025cites this paper
• Targeting base excision repair in precision oncology.

  2025cites this paper
• Targeted DNA damage repair: old mechanisms and new opportunities in clear cell renal cell carcinoma

  2024cites this paper
• Assay design for analysis of human uracil DNA glycosylase.

  2023cites this paper
• Identification of a new and diverse set of Mycobacterium tuberculosstais uracil-DNA glycosylase (MtUng) inhibitors using structure-based virtual screening: experimental validation and molecular dynamics studies.

  2022cites this paper
• Energy Landscapes for Base-Flipping in a Model DNA Duplex

  2022cites this paper
• An effective human uracil-DNA glycosylase inhibitor targets the open pre-catalytic active site conformation

  2021cites this paper
• Drug screening strategies using metal-based luminescent probes

  2021cites this paper
• Viruses with U-DNA: New Avenues for Biotechnology

  2021cites this paper
• A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme

  2021cites this paper
• The Essential Co-Option of Uracil-DNA Glycosylases by Herpesviruses Invites Novel Antiviral Design

  2020cites this paper
• A robust photoluminescence screening assay identifies uracil-DNA glycosylase inhibitors against prostate cancer

  2020cites this paper
• Focus on DNA Glycosylases—A Set of Tightly Regulated Enzymes with a High Potential as Anticancer Drug Targets

  2020cites this paper
• Base excision repair and its implications to cancer therapy

  2020cites this paper
• Synthesis and anti-parasitic activity of N-benzylated phosphoramidate Mg2+-chelating ligands.

  2020cites this paper
• Inhibitors of DNA Glycosylases as Prospective Drugs

  2020cites this paper
• Targeting uracil-DNA glycosylases for therapeutic outcomes using insights from virus evolution.

  2019cites this paper
• Nucleic acid-based fluorescent methods for the determination of DNA repair enzyme activities: A review.

  2019cites this paper
• Entrapment of an adenine derivative by a photo-irradiated uracil-functionalized micelle confers controlled self-assembly behavior.

  2019cites this paper
• Is Uracil-DNA Glycosylase UNG2 a New Cellular Weapon Against HIV-1?

  2019cites this paper
• Targeting BER enzymes in cancer therapy.

  2018cites this paper
• Dynamic Combinatorial Libraries

  2017cites this paper
• Design, synthesis, crystal structure and fungicidal activity of (E)-5-(methoxyimino)-3,5-dihydrobenzo[e][1,2]oxazepin-4(1H)-one analogues.

  2017cites this paper
• Label-free fluorescence turn-on detection of uracil DNA glycosylase activity based on G-quadruplex formation.

  2016cites this paper
• A DNA array based on clickable lesion-containing hairpin probes for multiplexed detection of base excision repair activities.

  2016cites this paper
• Structural plasticity in Mycobacterium tuberculosis uracil-DNA glycosylase (MtUng) and its functional implications.

  2015cites this paper
• A label-free and sensitive fluorescent method for the detection of uracil-DNA glycosylase activity.

  2015cites this paper
• Synthetic derivatives of the SUMO consensus sequence provide a basis for improved substrate recognition.

  2015cites this paper
• Hydroxybenzaldoximes Are D‐GAP‐Competitive Inhibitors of E. coli 1‐Deoxy‐D‐Xylulose‐5‐Phosphate Synthase

  2015cites this paper
• A High-Throughput Enzyme-Coupled Assay for SAMHD1 dNTPase

  2015cites this paper
• Identification of an Atg8-Atg3 Protein–Protein Interaction Inhibitor from the Medicines for Malaria Venture Malaria Box Active in Blood and Liver Stage Plasmodium falciparum Parasites

  2014cites this paper
• Dynamic combinatorial/covalent chemistry: a tool to read, generate and modulate the bioactivity of compounds and compound mixtures.

  2014cites this paper
• Microscopic mechanism of DNA damage searching by hOGG1

  2014cites this paper
• Probing secondary interactions in biomolecular recognition by dynamic combinatorial chemistry.

  2014cites this paper
• Irreversible inhibition of DNA polymerase β by small-molecule mimics of a DNA lesion.

  2014cites this paper
• Elucidating a role for uracil DNA glycosylase (UNG)-initiated DNA base excision repair in the cellular sensitivity to the antifolate, pemetrexed

  2014cites this paper
• Inhibition of DNA Glycosylases via Small Molecule Purine Analogs

  2013cites this paper
• Charge Transfer Complexes of Some Heterocyclic Aromatic Amines with π‐Organic Acceptors in Polar Solvents

  2013cites this paper
• Vpr expression abolishes the capacity of HIV-1 infected cells to repair uracilated DNA

  2013cites this paper
• A rapid microfluidic synthesis of [18F]fluoroarenes from nitroarenes.

  2013cites this paper
• Distinct mechanisms of DNA repair in mycobacteria and their implications in attenuation of the pathogen growth.

  2012cites this paper
• Role of host factors in bacteriophage φ29 DNA replication.

  2012cites this paper
• Biological activity of anti-miR-221 PeptideNucleic Acids and relative building blocks

  2012cites this paper
• Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosphatase.

  2011cites this paper
• Timing Facilitated Site Transfer of an Enzyme on DNA

  2011cites this paper
• Novel dimeric structure of phage ϕ29-encoded protein p56: insights into uracil-DNA glycosylase inhibition

  2011cites this paper
• Effect of the thymidylate synthase inhibitors on dUTP and TTP pool levels and the activities of DNA repair glycosylases on uracil and 5-fluorouracil in DNA.

  2011cites this paper
• Characterization of Bacillus subtilis uracil‐DNA glycosylase and its inhibition by phage φ29 protein p56

  2011cites this paper
• Small‐molecule Inhibitors of DNA Base Excision Repair

  2010cites this paper
• A rapid oxime linker-based library approach to identification of bivalent inhibitors of the Yersinia pestis protein-tyrosine phosphatase, YopH.

  2010cites this paper
• Structure of uracil-DNA glycosylase from Mycobacterium tuberculosis: insights into interactions with ligands.

  2010cites this paper
• New uracil dimers showing erythroid differentiation inducing activities.

  2009cites this paper
• Impact of linker strain and flexibility in the design of a fragment-based inhibitor

  2009cites this paper
• Dynamic mixtures and combinatorial libraries: imines as probes for molecular evolution at the interface between chemistry and biology.

  2009cites this paper
• Matching active site and substrate structures for an RNA editing reaction.

  2009cites this paper
• Synthesis of a Homologous Series of Side Chain Extended Orthogonally-Protected Aminooxy-Containing Amino Acids.

  2008cites this paper
• Unique features of the structure and interactions of mycobacterial uracil-DNA glycosylase: structure of a complex of the Mycobacterium tuberculosis enzyme in comparison with those from other sources.

  2008cites this paper
• Potent Inhibition of Human Apurinic/Apyrimidinic Endonuclease 1 by Arylstibonic Acids

  2008cites this paper
• Design, synthesis and spectroscopic studies of resveratrol aliphatic acid ligands of human serum albumin.

  2008cites this paper
• Molecular Diagnosis of Common Viral Infectious Diseases Based on Real Time PCR

  2008cites this paper
• POTENT INHIBITION OF HUMAN AP ENDONUCLEASE 1 BY ARYLSTIBONIC ACIDS

  2007cites this paper
• Protein p56 from the Bacillus subtilis phage ϕ29 inhibits DNA-binding ability of uracil-DNA glycosylase

  2007cites this paper
• Cross-linked and functionalized polyester materials constructed using ketoxime ether linkages.

  2007cites this paper
• The catalytic power of uracil DNA glycosylase in the opening of thymine base pairs.

  2006cites this paper
• Overexpression, purification, crystallization and preliminary X-ray analysis of uracil N-glycosylase from Mycobacterium tuberculosis in complex with a proteinaceous inhibitor.

  2006cites this paper
• Direct screening of a dynamic combinatorial library using mass spectrometry

  2006cites this paper
• Synthesis and high-throughput evaluation of triskelion uracil libraries for inhibition of human dUTPase and UNG2.

  2006cites this paper
• Mimicking damaged DNA with a small molecule inhibitor of human UNG2

  2006influential citation
• Rational Inhibitors of DNA Base Excision Repair Enzymes: New Tools for Elucidating the Role of BER in Cancer Chemotherapy. Addendum

  2006cites this paper
• C6-substituted analogues of 8-azanebularine: probes of an RNA-editing enzyme active site.

  2006cites this paper